26-28/01/2024

Hyatt Regency Hotel, Thessaloniki

IASIS PHARMA participated in the 1st International Congress “Thessderma Innovation, Inspiration, Interaction” which held on January 26-28, 2024, at the Hyatt Regency Hotel, in Thessaloniki.

The conference was organized by the A’ & B’ Dermatology Clinics of the Aristotle University of Thessaloniki (A.U.Th.).

Dermatologists from all over Greece who attended the congress had the chance to visit IASIS PHARMA exhibition stand and informed of IASIS major Dermatological products:

  • Isotroin®/Isotretinoin, (in the new & unique 30mg dosage) indicated for Severe forms of Acne that are resistant to treatment with systemically administered antibiotics and topical therapy. Isotroin® 30mg completes the range of the other Isotroin® contents (10mg, 20mg & 40mg).
  • Combi®, a combination of fluprednidene (1mg) + miconazole (20mg) cream (50gr) for the treatment of Inflammatory Dermatomycoses.
  • Modiwart®/Ιmiquimod (12,5mg/sach), an innovative modifier of the immune response system indicated for the treatment of: External Genital Warts, Superficial Basal Cell Carcinomas and Aktinic Keratoses.

 

thessderma_2024-copy